← All trials
NCT04481139
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 21, 2020
- Primary completion
- Jan 9, 2023
- Completion date
- Feb 23, 2023
- First posted
- Jul 22, 2020
- Last posted
- Nov 13, 2020
- Enrollment
- 480
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hengrui Therapeutics, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.